3 Dividend Stocks Worth Buying Now?

Follow the Burst at SummayMoney.com

Thursday, January 9th 2025

3 Dividend Stocks Worth Buying Now?

Thanks to surging stock prices over the past two years, dividend yields on major stock indices have fallen to fairly low levels. The S&P 500, for instance, currently carries an average yield of just 1.3%.

 

The mature companies in the Dow Jones Industrial Average fare a bit better, and some of them offer yields that exceed the S&P 500 several times over. Here, we take a look at three of the highest-yield stocks in the DJIA.

 

Get the full details here

Sponsored
Curious About AI's Next Big Winners?
Unlock invaluable investment secrets and peer into the future of the AI sector. This report is your indispensable guide, whether you're a seasoned pro or someone looking to master the AI realm. Learn More
Privacy Policy/Disclosures

Burst Content You May Have Missed

1 ETF Set To Beat The Market in 2025?

2024 was another banner year for the US stock market, with the S&P 500 notching a gain of 23%. Dwarfing even this return, though, was that of the Financial Select Sector SPDR ETF (XLF), which has delivered a 29.7% return over the last 12 months.

 

Get the full details here

Sponsored
Will Trump's Executive Order Spark the Biggest Stock Boom Ever?
America's New Manhattan Project could kick off on January 20, and we believe $113 billion will be aimed at beating China in the AI arms race. Find out details on the 7 stocks poised for explosive growth in this historic moment. Find out how to get 'Trump's $113 Billion ASI Portfolio' now! Click here to learn more.
Privacy Policy/Disclosures

1 Rare Stock Buffett Is Buying

Warren Buffett has spent 2024 stockpiling cash, even going so far as to sell off sizeable pieces of some of his largest investments. Recently, though, Berkshire Hathaway announced that it had made some modest acquisitions, including the addition of nearly 388,000 shares of domain name registry service Verisign (NASDAQ:VRSN).

 

Get the full details here

Sponsored
Oil Surge Predicted - But Are You Ready?
Do you own oil and gas stocks? Or are you thinking about buying some? If so, you need to see my #1 oil play for 2025. But it's NOT oil stocks, futures, or anything you've likely heard about. Rather, it's an unusual way to potentially bank monthly income from the oil and gas markets. Learn More Here.
Privacy Policy/Disclosures

Massive Upside In Big Money Pharma Favorite?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.

 

Get the full details here

- G. O'Fiachra

 

The Burst by Summa Money | World Class Investing

 

We value your feedback: Please let us know what you think about our investing ideas so far, and any recommendations you may have for increasing the value of this newsletter. Please follow this link for a quick, 2-minute survey

You Might Also Like:

Follow the Burst at SummayMoney.com

Advertising Disclosure: This email may contain paid advertisements.

Summa Money publishes 4 newsletters with various areas of focus. The Ivy is delivered 3x per week with a focus on investments that could generate passive income. The Burst is delivered 2x per week with a focus on growth stocks. The Spotlight is delivered 1x per week with a focus on high potential stocks and economic insights. The Daily is an occasional newsletter with a focus on the best investing stories and news from around the world.

We hope you enjoy them all, but feel free to unsubscribe from the content you do not want to receive.

If you do not want to receive emails from us, you can follow this link to unsubscribe. or click the unsubscribe link at the bottom of the email that you do not want to receive.

If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking the unsubscribe link at the bottom of this email. If you have any questions, please send an email with your questions to support@summamoney.com.

Nothing in this email should be considered personalized financial advice. We strongly urge you to read our full disclaimer here.

If you can't see this message, view it in your browser.

You are receiving this e-mail at punjabsvera@gmail.com as a part of your free subscription to the Burst Newsletter.

To read our privacy policy follow this link. or If you do not want to receive emails from us, you can follow this link to unsubscribe.

To unsubscribe by mail, write us at: Summa Money | 2319 N Andrews Ave. Fort Lauderdale, FL 33311

Website: Summa Money

Nothing in this email should be considered personalized financial advice. Staff members at Summa Money are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice.

Copyright 2024 Summa Money. All rights reserved.

If you do not want to receive emails from us, you can follow this link to unsubscribe. FROM THE BURST NEWSLETTER

Advertise With Us


In order to unsubscribe from this mailing list, please click here

Post a Comment

Previous Post Next Post

Contact Form